Explorer les evidences

4,3 %Of 47 patients with type 1 diabetes, 2 (4.3%) had TPO autoantibodies.

Cameroundiabète de type 1 · TPO autoantibodiespublié 2006Clinical immunology (Orlando, Fla.)europe_pmcdocument de 10 observations

21,31 %The overall COVID-19 PCR-positivity rate was 21.31% among 291 participants.

CamerounCOVID-19observé November 2020 to July 2021publié 2023VirusesOpenAlexdocument de 12 observationsDOI 10.3390/v15020407

15,1 %The prevalence of undernutrition in elderly patients with type 2 diabetes mellitus was 15.1% according to the GLIM criteria.

Cameroundiabète de type 2publié 2024Nutritional Status of Elderly Patients with Type 2 Diabetes Mellitus: Case of a Regional Heurope_pmcdocument de 7 observationsDOI 10.21203/rs.3.rs-4047556/v1

143 participantsA total of 143 HIV-infected Cameroonians aged 21 years or above were recruited in the study.

CamerounVIH/sidapublié 2013Diabetes & metabolismeurope_pmcdocument de 12 observations

2,2 HbA1c_pointsNon-surgical periodontal treatment markedly improved glycaemic control with an attributable reduction of 2.2 points of HbA1c in poorly controlled T2D patients in a sub-Saharan setting.

Cameroundiabète de type 2publié 2018BMC oral healtheurope_pmcdocument de 6 observations

82,4 %The prevalence of virological suppression was 82.4% overall among adult patients receiving antiretroviral therapy in the Centre and Littoral regions of Cameroon.

CamerounVIH/sidapublié 2019HIV medicineeurope_pmcdocument de 5 observationsDOI 10.1111/hiv.12681

25,2 %A total of 25.2% of participants were overweight yet metabolically healthy.

Camerounsyndrome métaboliqueobservé 1994publié 2015Diabetology & metabolic syndromeeurope_pmcDOI 10.1186/s13098-015-0016-5

7,8 %Adult HIV prevalence (≥18 years) was 7.8% in 2011 (179/2,282 adults).

CamerounVIH/sidaobservé 2011publié 2012Journal of the International AIDS Societyeurope_pmcdocument de 39 observations

1,3 %P. falciparum/P. ovale/P. malariae co-infections accounted for 1.3% of cases based on PCR results.

CamerounP. falciparum/P. ovale/P. malariaepublié 2023Parasites & vectorseurope_pmcdocument de 16 observationsDOI 10.1186/s13071-022-05635-7

74,3 %The FC27 allelic family prevalence was 74.3% in Mfou.

CamerounpaludismeHAL · Unilimdocument de 106 observations

23,6 %Among 407 patients on first-line antiretroviral treatment in rural Cameroon, 96 (23.6%) had unsuppressed viral load.

CamerounVIH/sidaobservé 2013-2014publié 2016Open Forum Infectious Diseaseseurope_pmcdocument de 3 observations

108 000 000 inhabitantsThe number of adults with diabetes in the world increased from 108 million in 1980 to 422 million in 2014.

Cameroundiabète (non précisé)observé 1980publié 2016Lancet (London, England)europe_pmcdocument de 7 observationsDOI 10.1016/s0140-6736(16)00618-8

0,43 SMDAmong HIV+ individuals, antiretroviral therapy use was associated with higher low-density lipoprotein with a standardized mean difference of 0.43.

Camerounlow-density lipoprotein · VIH/sidapublié 2013International journal of epidemiologyeurope_pmcdocument de 10 observationsDOI 10.1093/ije/dyt198

1 %If post-2000 trends continue, the probability of meeting the global target of halting the rise in the prevalence of diabetes by 2025 at the 2010 level worldwide is 1% for women.

Cameroundiabète (non précisé)observé 2025publié 2016Lancet (London, England)europe_pmcdocument de 7 observationsDOI 10.1016/s0140-6736(16)00618-8

0,33 coefficientHoloTC was positively associated with the metabolic syndrome score in unadjusted analysis (coefficient 0.33, 95% CI: 0.10 to 0.56).

Camerounsyndrome métaboliquepublié 2021Nutrientseurope_pmcdocument de 9 observationsDOI 10.3390/nu14010178

12,3 %In the ANRS 12313 NAMSAL trial, the incidence of obesity over the first 48 weeks was 12.3% in the dolutegravir group versus 5.4% in the efavirenz group.

CamerounobésitéHAL · Unilimdocument de 25 observations

158 mmHgAfter one month of spironolactone treatment, office blood pressure in the spironolactone group decreased from 158 ± 17/86 ± 11 mmHg to 125 ± 11/72 ± 8 mmHg in Cameroonian type 2 diabetic patients with resistant hypertension.

Cameroundiabète de type 2 · resistant hypertensionpublié 2016BMC research noteseurope_pmcdocument de 5 observations

-1,18 mmHg_per_SD_differenceAn inverse association was observed between serum folate and diastolic blood pressure (−1.18, 95% CI: −2.16 to −0.20), unaffected by adjustment for confounders including PAEE and holoTC.

Camerouncardiometabolic diseasepublié 2021Current developments in nutritioneurope_pmcdocument de 6 observations

0,7 %The median 5-year cardiovascular risk was 0.7% according to the Framingham equation.

Camerounmaladies cardiovasculairespublié 2017BMJ openeurope_pmcdocument de 7 observations

53 per_1000La proportion de cas de paludisme confirmés (testés positifs) pour 1000 personnes par an était de 53 pour mille en 2013.

Camerounpaludismeobservé 2013HAL · Unilimdocument de 98 observations

6,6 unitsCapsaicin did not significantly reduce neuropathic pain in the intervention group after 8 weeks, with a mean pain intensity of 6.6±1.1 compared to 5.4±1.0 in the placebo group (p=0.55).

Cameroundiabetic peripheral neuropathypublié 2020The Efficacy of topical Capsaicin in the management of painful diabetic peripheral neuropaeurope_pmcdocument de 6 observationsDOI 10.21203/rs.3.rs-19190/v1

22 %The prevalence of overweight among males was 22.0% in Jamaica.

Camerounobésitépublié 2007Public health nutritioneurope_pmcdocument de 9 observationsDOI 10.1017/s1368980007246762

10,4 %Pretreatment HIV drug resistance (PDR) prevalence among all antiretroviral therapy (ART) initiators in Cameroon was 10.4% (95% CI 5.4%–19.1%).

CamerounVIH/sidaobservé 2015publié 2018Journal of Antimicrobial ChemotherapyOpenAlexdocument de 12 observationsDOI 10.1093/jac/dky221

7,3 %Borderline hypertension was detected in 7.3% of rural men in Cameroon.

Camerounborderline hypertensionpublié 1998International journal of epidemiologyeurope_pmcdocument de 10 observationsDOI 10.1093/ije/27.2.181

9,2 %The mean HbA1c was 9.2 ± 2.5%.

Cameroundiabète de type 1publié 2019BMC research noteseurope_pmcdocument de 4 observationsDOI 10.1186/s13104-019-4054-1